SKion GmbH

State attorneys general honed in on another segment of the generic drug industry, topical products, in their third suit alleging manufacturers and individual executives engaged in an overarching consp

The New Jersey-based Slayback Pharma LLC has announced the closing of a $60m financing by the private equity firm KKR, putting the spotlight on investment and mergers and acquisition (M&A) appetite in

The New Jersey-based Slayback Pharma LLC has announced the closing of a $60m financing by the private equity firm KKR, putting the spotlight on investment and mergers and acquisition (M&A) appetite in

Drug recalls continued at historic rates in 2014 as a surge in contamination issues persisted for a fifth straight year. FDA reported 1,335 drug recalls last year, edging out 2012 for third place afte